Abstract
Highly up-regulated in liver cancer (HULC) is a cancer-associated long non-coding RNA (lncRNA) which may regulate expression of other genes by working as a competing RNA for microRNAs. In the current study, we assessed transcript levels of this lncRNA in peripheral blood of multiple sclerosis (MS) patients and healthy persons to evaluate its possible role in the pathogenesis of this inflammatory disease and its diagnostic power. The results of Multilevel Bayesian showed no significant difference between cases and controls (P = 0.002, 95% confidence interval (CI) = [3.08, 13.3]). However, based on the results of Quantile regression, there was a significant difference in HULC expression between cases and controls after controlling the effects of sex and age (P = 0.002, 95% CI = [3.08, 13.3]) which shows different trends in males and females. HULC expression was inversely correlated with age of male subjects but not female subjects. HULC transcript levels had 91.1% accuracy in diagnosis of MS disease (Specificity: 80%, Sensitivity: 86.6%). The diagnostic power of HULC was higher in male subjects aged less than 50 years (AUC = 0.923, Specificity: 80%, Sensitivity: 100%). The present study shows the possibility of application of transcript levels of HULC as diagnostic marker in MS disease. However, future studies with larger sample sizes are necessary to validate our results.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bui T, Sequeira J, Wen TC, Sola A, Higashi Y, Kondoh H, Genetta T (2009) ZEB1 links p63 and p73 in a novel neuronal survival pathway rapidly induced in response to cortical ischemia. PLoS One 4:e4373. https://doi.org/10.1371/journal.pone.0004373
Hammerle M et al (2013) Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology (Baltimore, Md) 58:1703–1712. https://doi.org/10.1002/hep.26537
Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, la Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122:2871–2883. https://doi.org/10.1172/jci63539
Jiang Z, Liu H (2018) Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX. J Cell Biochem 119:4482–4495. https://doi.org/10.1002/jcb.26555
Kong D, Wang Y (2018) Knockdown of lncRNA HULC inhibits proliferation, migration, invasion, and promotes apoptosis by sponging miR-122 in osteosarcoma. J Cell Biochem 119:1050–1061. https://doi.org/10.1002/jcb.26273
Li SP, Xu HX, Yu Y, He JD, Wang Z, Xu YJ, Wang CY, Zhang HM, Zhang RX, Zhang JJ, Yao Z, Shen ZY (2016) LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget 7:42431–42446. https://doi.org/10.18632/oncotarget.9883
Nicot A (2009) Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci-Landmrk 14:4477–4515. https://doi.org/10.2741/3543
Oldoni E et al (2017) Long non coding RNA expression profile in Peripheral Blood Mononuclear Cells from multiple sclerosis patients: potential biomarkers of disease susceptibility and progression. In: Multiple Sclerosis Journal, 2017. Sage Publications LTD 1 Olivers Yard, 55 City Road, London EC1Y 1SP, England, pp 580–581
Panzitt K, Tschernatsch MMO, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder R, Trauner M, Zatloukal K (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132:330–342. https://doi.org/10.1053/j.gastro.2006.08.026
Selmaj I, Cichalewska M, Namiecinska M, Galazka G, Horzelski W, Selmaj KW, Mycko MP (2017) Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol 81:703–717. https://doi.org/10.1002/ana.24931
Vidaurre OG et al (2015) Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics (vol 137, pg 2271, 2014). Brain 138:e367. https://doi.org/10.1093/brain/awv090
Wendlandt EB, Graff JW, Gioannini TL, McCaffrey AP, Wilson ME (2012) The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-kappaB activation. Innate Immunity 18:846–855. https://doi.org/10.1177/1753425912443903
Acknowledgements
The current study was supported by a grant from Shahid Beheshti University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sayad, A., Taheri, M., Arsang-Jang, S. et al. Hepatocellular carcinoma up-regulated long non-coding RNA: a putative marker in multiple sclerosis. Metab Brain Dis 34, 1201–1205 (2019). https://doi.org/10.1007/s11011-019-00418-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-019-00418-z